Alteration of HB-EGF in psoriatic epidermis with the treatment of retinoid acid

  • Yan Zheng
  • , Zhenhui Peng
  • , Shengshun Tan
  • , Yanping Xi
  • , Yili Wang
  • , Baochang Lai

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Objective. To investigate the mechanism of tazarotene in active psoriasis vulgaris. Methods. HB-EGF protein in active psoriatic lesions before and 10 days after the treatment of tazarotene was detected by immunohistochemistry. Results. There was nearly no expression of HB-EGF in psoriatic lesions (9.1%), but after the treatment by tazarotene, there was expression of HB-EGF not only in basal layer (95.5%), but also focal expression in suprabasal layers of epidermis (77.3%). Conclusion. Tazarotene inhibit proliferation and induce apoptosis of keratinocytes through upregulating expression of HB-EGF in psoriatic epidermis.

Original languageEnglish
Pages (from-to)41-43
Number of pages3
JournalAcademic Journal of Xi'an Jiaotong University
Volume15
Issue number1
StatePublished - May 2003

Keywords

  • HB-EGF
  • Psoriasis
  • Suprabasal epidermis

Fingerprint

Dive into the research topics of 'Alteration of HB-EGF in psoriatic epidermis with the treatment of retinoid acid'. Together they form a unique fingerprint.

Cite this